{"nct_id":"NCT05609630","title":"Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-10-02","start_date_type":"ACTUAL","primary_completion_date":"2029-06","primary_completion_date_type":"ESTIMATED","completion_date":"2029-06","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}